Kaneda Kazuko 兼田加珠子 (中島加珠子)

… Alternative Names

中島加珠子

KANEDA Kazuko 兼田加珠子

Less

Researcher Number	00533209
Other IDs
Affiliation (Current)	2025: 大阪大学, 放射線科学基盤機構, 教授 2025: 大阪大学, 大学院理学研究科, 教授
Affiliation (based on the past Project Information) *help	2021 – 2025: 大阪大学, 大学院理学研究科, 教授 2018 – 2024: 大阪大学, 放射線科学基盤機構, 特任准教授(常勤) 2022: 大阪大学, 理学研究科, 教授 2016: 大阪大学, 理学研究科, 特任助教(常勤) 2015: 宮崎大学, 医学部, 助教 … More 2014 – 2015: 大阪大学, 医学(系)研究科(研究院), 特任助教(常勤) 2014: 大阪大学, 医学(系)研究科(研究院), 助教 2014: 大阪大学, 大学院医学系研究科, 特任助教 2012 – 2013: 宮崎大学, 医学部, 助教 Less
Review Section/Research Field	Principal Investigator Basic Section 52040:Radiological sciences-related / Basic Section 50020:Tumor diagnostics and therapeutics-related / General pharmacology / Biological pharmacy Except Principal Investigator Basic Section 52040:Radiological sciences-related / Basic Section 31010:Nuclear engineering-related / Medium-sized Section 52:General internal medicine and related fields / Pathological medical chemistry / Morphological basic dentistry
Keywords	Principal Investigator アミノ酸トランスポーター / がん / トランスポーター / アミノ酸 / LAT1 / アスタチン211 / アルファ線 / 核医学治療 / インテグリン / 低侵襲 … More / がん治療 / At-211 / 難治性がん / 核医学治療薬 / 栄養制御 / 接着分子 / 抗体医薬 / 白血病 / 薬剤耐性 / 転写因子 … More Except Principal Investigator アスタチン / アルファ線 / α線 / 核医学治療 / 211At / FAP / 核医学 / 線維芽細胞活性化タンパク質 / 線量評価 / PHITS / マイクロドジメトリ / 線量評価システム / 標的核医学治療 / 47Sc / 癌関連線維芽細胞 / RI / 放射性核種 / イメージングプローブ / 放射線 / 発光 / tyrosine / astatine / TAT / ペプチド / アミノ酸 / 放射性医薬品 / amino acids / radiotheranostics / targeted alpha therapy / PET / がん間質 / FAPI / がん関連線維芽細胞 / アルファ線治療 / ランタン / 迅速反応性 / 安定度定数 / ガドリニウム / アクチニウム / ランタノイド / キレート剤 / ゲノム異常 / リン酸化異常 / 感染防御 / ATLL / NIK / NF-kB / PTEN / NDRG2 / 成人T細胞白血病 / HTLV-1 / 骨分化 / 転写因子 Less

転移・再発がんを標的とする革新的アルファ線がん治療薬の開発Principal Investigator
- Principal Investigator
  
  兼田加珠子 (中島加珠子)
- Project Period (FY)
  2025 – 2028
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 52040:Radiological sciences-related
- Research Institution
  The University of Osaka
Development of innovative alpha therapy targeting cancer-associated fibroblasts
- Principal Investigator
  
  渡部直史
- Project Period (FY)
  2024 – 2026
- Research Category
  
  Grant-in-Aid for Scientific Research (B)
- Review Section
  
  Basic Section 52040:Radiological sciences-related
- Research Institution
  Osaka University
Research on alpha-particle therapeutics for targeting SGLT2
- Principal Investigator
  
  白神宜史
- Project Period (FY)
  2024 – 2026
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 52040:Radiological sciences-related
- Research Institution
  Osaka University
Development of imaging probes emitting radiation and fluorescence in a single molecule unit
- Principal Investigator
  
  Yoshimura Takashi
- Project Period (FY)
  2021 – 2023
- Research Category
  
  Grant-in-Aid for Scientific Research (B)
- Review Section
  
  Basic Section 31010:Nuclear engineering-related
- Research Institution
  Osaka University
A challenge to low-invasive one-day cancer treatment using alpha emitting nuclidePrincipal Investigator
- Principal Investigator
  
  Kaneda-Nakashima Kazuko
- Project Period (FY)
  2021 – 2023
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 52040:Radiological sciences-related
- Research Institution
  Osaka University
Interdisciplinary study for the development of dosimetry system for targeted alpha therapy
- Principal Investigator
  
  佐藤達彦
- Project Period (FY)
  2021 – 2025
- Research Category
  
  Grant-in-Aid for Scientific Research (B)
- Review Section
  
  Basic Section 52040:Radiological sciences-related
- Research Institution
  Japan Atomic Energy Agency
Targeted alpha therapy for patients with tumor
- Principal Investigator
  
  Shirakami Yoshifumi
- Project Period (FY)
  2020 – 2022
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 52040:Radiological sciences-related
- Research Institution
  Osaka University
Development of stable and rapid reactive chlating agent for MRI and Targeted Alpha Therapy
- Principal Investigator
  
  Yoshimura Takashi
- Project Period (FY)
  2019 – 2020
- Research Category
  
  Grant-in-Aid for Challenging Research (Exploratory)
- Review Section
  
  Medium-sized Section 52:General internal medicine and related fields
- Research Institution
  Osaka University
Development of Nuclear Medicine Therapy targeting Cancer Stroma
- Principal Investigator
  
  Watabe Tadashi
- Project Period (FY)
  2019 – 2021
- Research Category
  
  Grant-in-Aid for Scientific Research (B)
- Review Section
  
  Basic Section 52040:Radiological sciences-related
- Research Institution
  Osaka University
Development of cancer missile therapy targeting amino acid transporter LAT1 by alpha emitting nuclidePrincipal Investigator
- Principal Investigator
  
  Kaneda Kazuko
- Project Period (FY)
  2018 – 2021
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 50020:Tumor diagnostics and therapeutics-related
- Research Institution
  Osaka University
Investigation of cancer specific survival system via LAT1/4F2hc-integrin complexPrincipal Investigator
- Principal Investigator
  
  Kaneda Kazuko
- Project Period (FY)
  2015 – 2016
- Research Category
  
  Grant-in-Aid for Young Scientists (B)
- Research Field
  
  General pharmacology
- Research Institution
  Osaka University
Analysis of ATL leukemogenesis through breakage of defense mechanism of HTLV-1 infection
- Principal Investigator
  
  Kazuhiro Morishita
- Project Period (FY)
  2013 – 2015
- Research Category
  
  Grant-in-Aid for Scientific Research (B)
- Research Field
  
  Pathological medical chemistry
- Research Institution
  University of Miyazaki
Investigation of survival strategy of refractory leukemia via integrinPrincipal Investigator
- Principal Investigator
  
  KANEDA Kazuko
- Project Period (FY)
  2013 – 2014
- Research Category
  
  Grant-in-Aid for Young Scientists (B)
- Research Field
  
  Biological pharmacy
- Research Institution
  Osaka University
  University of Miyazaki
Investigation of MEL1/PRDM16 function in bone differentiation
- Principal Investigator
  
  IGAWA Kaori
- Project Period (FY)
  2012 – 2014
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Morphological basic dentistry
- Research Institution
  University of Miyazaki

All 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2013 2012 Other

All Journal Article Presentation Patent

[Journal Article] Comparison of Nuclear Medicine Therapeutics Targeting PSMA among Alpha-Emitting Nuclides2024
- Author(s)
  Kaneda-Nakashima Kazuko、Shirakami Yoshifumi、Kadonaga Yuichiro、Watabe Tadashi、Ooe Kazuhiro、Yin Xiaojie、Haba Hiromitsu、Shirasaki Kenji、Kikunaga Hidetoshi、Tsukada Kazuaki、Toyoshima Atsushi、Cardinale Jens、Giesel Frederik L.、Fukase Koichi
- Journal Title
  
  International Journal of Molecular Sciences
  
  Volume: 25 Issue: 2 Pages: 933-933
- DOI
  10.3390/ijms25020933
- Peer Reviewed / Open Access / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-21K07619, KAKENHI-PROJECT-23K21426
[Journal Article] Fibroblast Activation Protein Inhibitor Theranostics2023
- Author(s)
  Kaneda-Nakashima Kazuko、Shirakami Yoshifumi、Kadonaga Yuichiro、Watabe Tadashi
- Journal Title
  
  PET Clinics
  
  Volume: 18 Issue: 3 Pages: 397-408
- DOI
  10.1016/j.cpet.2023.02.005
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-21K07619
[Journal Article] Evaluation of Astatine-211-Labeled Fibroblast Activation Protein Inhibitor (FAPI): Comparison of Different Linkers with Polyethylene Glycol and Piperazine2023
- Author(s)
  Aso A、Nabetani H、Matsuura Y、Kadonaga Y、Shirakami Y、Watabe T、Yoshiya T、Mochizuki M、Ooe K、Kawakami A、Jinno N、Toyoshima A、Haba H、Wang Y、Cardinale J、Giesel FL、Shimoyama A、Kaneda-Nakashima K、Fukase K
- Journal Title
  
  International Journal of Molecular Sciences
  
  Volume: 24 Issue: 10 Pages: 8701-8701
- DOI
  10.3390/ijms24108701
- Peer Reviewed / Open Access / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-21K07619, KAKENHI-PROJECT-20H05675
[Journal Article] Inhibition of cancer-type amino acid transporter LAT1 suppresses B16-F10 melanoma metastasis in mouse models2023
- Author(s)
  Shi Zitong、Kaneda-Nakashima Kazuko、Ohgaki Ryuichi、Xu Minhui、Okanishi Hiroki、Endou Hitoshi、Nagamori Shushi、Kanai Yoshikatsu
- Journal Title
  
  Scientific Reports
  
  Volume: 13 Issue: 1 Pages: 13943-13943
- DOI
  10.1038/s41598-023-41096-3
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-22K06856, KAKENHI-PROJECT-21K07619, KAKENHI-PROJECT-22K19404, KAKENHI-PROJECT-21K20742, KAKENHI-PROJECT-21H03365, KAKENHI-PROJECT-23K24071
[Journal Article] Effect to Therapy of Sodium-Iodine Symporter Expression by Alpha-Ray Therapeutic Agent via Sodium/Iodine Symporter2022
- Author(s)
  Kaneda-Nakashima Kazuko、Shirakami Yoshifumi、Watabe Tadashi、Ooe Kazuhiro、Yoshimura Takashi、Toyoshima Atsushi、Wang Yang、Haba Hiromitsu、Fukase Koichi
- Journal Title
  
  International Journal of Molecular Sciences
  
  Volume: 23 Issue: 24 Pages: 15509-15509
- DOI
  10.3390/ijms232415509
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-21K07619
[Journal Article] Dioxetane Derivative Containing Carboxy Group as a Chemiluminophore‐Introducing Reagent2022
- Author(s)
  Nohara Yukie、Masuda Shun、Kaneda‐Nakashima Kazuko、Shirakami Yoshifumi、Matsumoto Masakatsu、Yoshiya Taku
- Journal Title
  
  ChemBioChem
  
  Volume: 23 Issue: 24 Pages: 1-5
- DOI
  10.1002/cbic.202200556
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-21K07619
[Journal Article] Substrate Study for Dihydroxyboryl Astatine Substitution Reaction with Fibroblast Activation Protein Inhibitor (FAPI)2022
- Author(s)
  Aso Ayaka、Kaneda-Nakashima Kazuko、Nabetani Hinako、Kadonaga Yuichiro、Shirakami Yoshifumi、Watabe Tadashi、Yoshiya Taku、Mochizuki Masayoshi、Koshino Yuki、Ooe Kazuhiro、Kawakami Atsuko、Jinno Naoya、Toyoshima Atsushi、Haba Hiromitsu、Wang Yang、Cardinale Jens、Giesel Frederik L.、Shimoyama Atsushi、Fukase Koichi
- Journal Title
  
  Chemistry Letters
  
  Volume: 51 Issue: 11 Pages: 1091-1094
- DOI
  10.1246/cl.220391
- Peer Reviewed / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-21K07619, KAKENHI-PROJECT-20H05675, KAKENHI-PROJECT-20K05749
[Journal Article] Astatine-211-Labeled Gold Nanoparticles for Targeted Alpha-Particle Therapy via Intravenous Injection2022
- Author(s)
  Huang Xuhao、Kaneda-Nakashima Kazuko、Kadonaga Yuichiro、Kabayama Kazuya、Shimoyama Atsushi、Ooe Kazuhiro、Kato Hiroki、Toyoshima Atsushi、Shinohara Atsushi、Haba Hiromitsu、Wang Yang、Fukase Koichi
- Journal Title
  
  Pharmaceutics
  
  Volume: 14 Issue: 12 Pages: 2705-2705
- DOI
  10.3390/pharmaceutics14122705
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-21K07619, KAKENHI-PROJECT-22K19112, KAKENHI-PROJECT-20H05675, KAKENHI-PROJECT-22KJ2124, KAKENHI-PROJECT-20K05749
[Journal Article] Role of Mel1/Prdm16 in bone differentiation and morphology2022
- Author(s)
  Kaneda-Nakashima Kazuko、Igawa Kaori、Suwanruengsri Mathurot、Naoyuki Fuke、Ichikawa Tomonaga、Funamoto Taro、Kurogi Shuji、Sekimoto Tomohisa、Yamashita Yoshihiro、Chosa Etsuo、Yamaguchi Ryoji、Morishita Kazuhiro
- Journal Title
  
  Experimental Cell Research
  
  Volume: 410 Issue: 2 Pages: 112969-112969
- DOI
  10.1016/j.yexcr.2021.112969
- Peer Reviewed / Open Access / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-21K07619, KAKENHI-PROJECT-21K07128
[Journal Article] Mathematical Model for Evaluation of Tumor Response in Targeted Radionuclide Therapy with 211At Using Implanted Mouse Tumor2022
- Author(s)
  Yonekura Yoshiharu、Toki Hiroshi、Watabe Tadashi、Kaneda-Nakashima Kazuko、Shirakami Yoshifumi、Ooe Kazuhiro、Toyoshima Atsushi、Nakajima Hiroo、Tomiyama Noriyuki、Bando Masako
- Journal Title
  
  International Journal of Molecular Sciences
  
  Volume: 23 Issue: 24 Pages: 15966-15966
- DOI
  10.3390/ijms232415966
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-21K07619
[Journal Article] Targeted α-therapy using astatine (211At)-labeled PSMA1, 5, and 6: a preclinical evaluation as a novel compound2022
- Author(s)
  Watabe Tadashi、Kaneda-Nakashima Kazuko、Shirakami Yoshifumi、Kadonaga Yuichiro、Ooe Kazuhiro、Wang Yang、Haba Hiromitsu、Toyoshima Atsushi、Cardinale Jens、Giesel Frederik L.、Tomiyama Noriyuki、Fukase Koichi
- Journal Title
  
  European Journal of Nuclear Medicine and Molecular Imaging
  
  Volume: 50 Issue: 3 Pages: 849-858
- DOI
  10.1007/s00259-022-06016-z
- Peer Reviewed / Open Access / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-21K07619, KAKENHI-PROJECT-20K08105
[Journal Article] Comparison of the Therapeutic Effects of [211At]NaAt and [131I]NaI in an NIS-Expressing Thyroid Cancer Mouse Model2022
- Author(s)
  Watabe Tadashi、Liu Yuwei、Kaneda-Nakashima Kazuko、Sato Tatsuhiko、Shirakami Yoshifumi、Ooe Kazuhiro、Toyoshima Atsushi、Shimosegawa Eku、Wang Yang、Haba Hiromitsu、Nakano Takashi、Shinohara Atsushi、Hatazawa Jun
- Journal Title
  
  International Journal of Molecular Sciences
  
  Volume: 23 Issue: 16 Pages: 9434-9434
- DOI
  10.3390/ijms23169434
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-21K07619, KAKENHI-PROJECT-23K21426
[Journal Article] Synthesis of [211At]4-astato-L-phenylalanine by dihydroxyboryl-astatine substitution reaction in aqueous solution2021
- Author(s)
  Shirakami Yoshifumi、Watabe Tadashi、Obata Honoka、Kaneda Kazuko、Ooe Kazuhiro、Liu Yuwei、Teramoto Takahiro、Toyoshima Atsushi、Shinohara Atsushi、Shimosegawa Eku、Hatazawa Jun、Fukase Koichi
- Journal Title
  
  Scientific Reports
  
  Volume: 11 Issue: 1 Pages: 12982-12982
- DOI
  10.1038/s41598-021-92476-6
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-18K07323, KAKENHI-PROJECT-21K07619
[Journal Article] Dispersion of Alpha-Nuclides during Animal Experiments2021
- Author(s)
  KANEDA-NAKASHIMA Kazuko、ZHANG Zijian、NAGATA Kojiro、SHIRASAKI Kenji、KIKUNAGA Hidetoshi、YAMAMURA Tomoo、OOE Kazuhiro、WATABE Tadashi、TOYOSHIMA Atsushi、YOSHIMURA Takashi、SHINOHARA Atsushi
- Journal Title
  
  Radiation Safety Management
  
  Volume: 20 Issue: 0 Pages: 29-38
- DOI
  10.12950/rsm.210519
- NAID
  130008112973
- ISSN
  1347-1511, 1884-9520
- Language
  English
- Data Source
  KAKENHI-PROJECT-18K07323
[Journal Article] Development of GGAG alpha camera system for targeted alpha radionuclide therapy research2021
- Author(s)
  Yamamoto S.、Watabe T.、Kaneda-Nakashima K.、Shirakami Y.、Ooe K.、Toyoshima A.、Teramoto T.、Shinohara A.、Hatazawa J.
- Journal Title
  
  Journal of Instrumentation
  
  Volume: 16 Issue: 06 Pages: P06009-P06009
- DOI
  10.1088/1748-0221/16/06/p06009
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-21K07619
[Journal Article] Dispersion of Alpha-Nuclides during Animal Experiments.2021
- Author(s)
  Kazuko KANEDA-NAKASHIMA, Zijian ZHANG, Kojiro NAGATA, Kenji SHIRASAKI, Hidetoshi KIKUNAGA, Tomoo YAMAMURA, Kazuhiro OOE, Tadashi WATABE, Atsushi TOYOSHIMA, Takashi YOSHIMURA, Atsushi SHINOHARA
- Journal Title
  
  Radiation Safety Management
  
  Volume: 20 Pages: 29-38
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-21K07619
[Journal Article] α‐Emitting cancer therapy using 211 At‐AAMT targeting LAT12021
- Author(s)
  Kaneda‐Nakashima Kazuko、Zhang ZiJian、Manabe Yoshiyuki、Shimoyama Atsushi、Kabayama Kazuya、Watabe Tadashi、Kanai Yoshikatsu、Ooe Kazuhiro、Toyoshima Atsushi、Shirakami Yoshifumi、Yoshimura Takashi、Fukuda Mitsuhiro、Hatazawa Jun、Nakano Takashi、Fukase Koichi、Shinohara Atsushi
- Journal Title
  
  Cancer Science
  
  Volume: 112 Issue: 3 Pages: 1132-1140
- DOI
  10.1111/cas.14761
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-18K05356, KAKENHI-PROJECT-20K08105, KAKENHI-PLANNED-15H05836, KAKENHI-PROJECT-16H05924, KAKENHI-PUBLICLY-20H04709, KAKENHI-PROJECT-19H03407, KAKENHI-PROJECT-18K07323, KAKENHI-PUBLICLY-20H04776, KAKENHI-PLANNED-21H05074, KAKENHI-PROJECT-20H05675, KAKENHI-PROJECT-20K05727, KAKENHI-PROJECT-20K05749
[Journal Article] Fibroblast activation protein targeted therapy using [177Lu]FAPI-46 compared with [225Ac]FAPI-46 in a pancreatic cancer model2021
- Author(s)
  Liu Yuwei、Watabe Tadashi、Kaneda-Nakashima Kazuko、Shirakami Yoshifumi、Naka Sadahiro、Ooe Kazuhiro、Toyoshima Atsushi、Nagata Kojiro、Haberkorn Uwe、Kratochwil Clemens、Shinohara Atsushi、Hatazawa Jun、Giesel Frederik
- Journal Title
  
  European Journal of Nuclear Medicine and Molecular Imaging
  
  Volume: 49 Issue: 3 Pages: 871-880
- DOI
  10.1007/s00259-021-05554-2
- Peer Reviewed / Open Access / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-18K07323, KAKENHI-PROJECT-21K07619, KAKENHI-PROJECT-19H03602, KAKENHI-PROJECT-23K21426
[Journal Article] Extended single-dose toxicity study of [211At]NaAt in mice for the first-in-human clinical trial of targeted alpha therapy for differentiated thyroid cancer2021
- Author(s)
  Watabe Tadashi、Kaneda-Nakashima Kazuko、Ooe Kazuhiro、Liu Yuwei、Kurimoto Kenta、Murai Takashi、Shidahara Yuka、Okuma Kenji、Takeuchi Masanori、Nishide Masayuki、Toyoshima Atsushi、Shinohara Atsushi、Shirakami Yoshifumi
- Journal Title
  
  Annals of Nuclear Medicine
  
  Volume: 35 Issue: 6 Pages: 702-718
- DOI
  10.1007/s12149-021-01612-9
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-18K07323, KAKENHI-PROJECT-21K07619, KAKENHI-PROJECT-23K21426
[Journal Article] Targeted alpha therapy using astatine (211At)-labeled phenylalanine: A preclinical study in glioma bearing mice2020
- Author(s)
  Watabe Tadashi、Kaneda-Nakashima Kazuko、Shirakami Yoshifumi、Liu Yuwei、Ooe Kazuhiro、Teramoto Takahiro、Toyoshima Atsushi、Shimosegawa Eku、Nakano Takashi、Kanai Yoshikatsu、Shinohara Atsushi、Hatazawa Jun
- Journal Title
  
  Oncotarget
  
  Volume: 11 Issue: 15 Pages: 1388-1398
- DOI
  10.18632/oncotarget.27552
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-18K07323, KAKENHI-PROJECT-19H03407
[Journal Article] Preclinical Evaluation of Radiation-Induced Toxicity in Targeted Alpha Therapy Using [211At] NaAt in Mice: A Revisit2020
- Author(s)
  Liu Yuwei、Watabe Tadashi、Kaneda-Nakashima Kazuko、Ooe Kazuhiro、Shirakami Yoshifumi、Toyoshima Atsushi、Shimosegawa Eku、Nakano Takashi、Shinohara Atsushi、Hatazawa Jun
- Journal Title
  
  Translational Oncology
  
  Volume: 13 Issue: 4 Pages: 100757-100757
- DOI
  10.1016/j.tranon.2020.100757
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-18K07323, KAKENHI-PROJECT-19H03602
[Journal Article] Development of high‐resolution YAP(Ce) x‐ray camera for the imaging of astatine‐211(At‐211) in small animals2020
- Author(s)
  Nakanishi Kouhei、Yamamoto Seiichi、Watabe Tadashi、Kaneda‐Nakashima Kazuko、Shirakami Yoshifumi、Ooe Kazuhiro、Toyoshima Atsushi、Shinohara Atsushi、Teramoto Takahiro、Hatazawa Jun、Kamada Kei、Yoshikawa Akira
- Journal Title
  
  Medical Physics
  
  Volume: 47 Issue: 11 Pages: 5739-5748
- DOI
  10.1002/mp.14455
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-18K07323, KAKENHI-PROJECT-17H06159, KAKENHI-PROJECT-19H00672, KAKENHI-PROJECT-20K20488
[Journal Article] Theranostics Targeting Fibroblast Activation Protein in the Tumor Stroma: 64Cu- and 225Ac-Labeled FAPI-04 in Pancreatic Cancer Xenograft Mouse Models2019
- Author(s)
  Watabe Tadashi、Liu Yuwei、Kaneda-Nakashima Kazuko、Shirakami Yoshifumi、Lindner Thomas、Ooe Kazuhiro、Toyoshima Atsushi、Nagata Kojiro、Shimosegawa Eku、Haberkorn Uwe、Kratochwil Clemens、Shinohara Atsushi、Giesel Frederik、Hatazawa Jun
- Journal Title
  
  Journal of Nuclear Medicine
  
  Volume: 61 Issue: 4 Pages: 563-569
- DOI
  10.2967/jnumed.119.233122
- Peer Reviewed / Open Access / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-18K07323, KAKENHI-PROJECT-19H03602
[Journal Article] Enhancement of astatine-211 uptake via the sodium iodide symporter by the addition of ascorbic acid in targeted alpha therapy of thyroid cancer2019
- Author(s)
  Watabe Tadashi、Kaneda-Nakashima Kazuko、Liu Yuwei、Shirakami Yoshifumi、Ooe Kazuhiro、Toyoshima Atsushi、Shimosegawa Eku、Fukuda Mitsuhiro、Shinohara Atsushi、Hatazawa Jun
- Journal Title
  
  Journal of Nuclear Medicine
  
  Volume: - Issue: 9 Pages: 1-43
- DOI
  10.2967/jnumed.118.222638
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-18K07323, KAKENHI-PROJECT-16K10277, KAKENHI-PROJECT-19H03602
[Journal Article] Enhancement of At-211 uptake in the thyroid gland- SPECT study in rats.2018
- Author(s)
  Liu Y, Watabe T, Kaneda-Nakashima K, Shirakami Y, Toyoshima A, Tatsumi M, Shimosegawa E, Fukuda M, Shinohara A, Hatazawa J.
- Journal Title
  
  J Nucl Med
  
  Volume: 59 Pages: 1129-1129
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-18K07323
[Journal Article] Species difference of astatine-211 uptakes in the whole body distribution: preclinical study using treated At-solution.2018
- Author(s)
  Watabe T, Kaneda-Nakashima K, Liu Y, Shirakami Y, Toyoshima A, Tatsumi M, Shimosegawa E, Fukuda M, Shinohara A, Hatazawa J.
- Journal Title
  
  J Nucl Med
  
  Volume: 59 Pages: 1269-1269
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-18K07323
[Journal Article] Suppression of GPR56 expression by pyrrole-imidazole polyamide represents a novel therapeutic drug for AML with high EVI1 expression2018
- Author(s)
  Saha Hasi Rani、Kaneda-Nakashima Kazuko、Shimosaki Shunsuke、Suekane Akira、Sarkar Bidhan、Saito Yusuke、Ogoh Honami、Nakahata Shingo、Inoue Kentaro、Watanabe Takayoshi、Nagase Hiroki、Morishita Kazuhiro
- Journal Title
  
  Scientific Reports
  
  Volume: 8 Issue: 1 Pages: 1-12
- DOI
  10.1038/s41598-018-32205-8
- Peer Reviewed / Open Access / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-18K07323, KAKENHI-PROJECT-17H03602, KAKENHI-PROJECT-17H03581
[Journal Article] Structure-activity relationship of a novel series of inhibitors for cancer type transporter L-type amino acid transporter 1 (LAT1).2017
- Author(s)
  Kongpracha P, Nagamori S, Wiriyasermkul P, Tanaka Y, Kaneda K, Okuda S, Ohgaki R, Kanai Y.
- Journal Title
  
  J Pharmacol Sci.
  
  Volume: 133 Issue: 2 Pages: 96-102
- DOI
  10.1016/j.jphs.2017.01.006
- Peer Reviewed / Acknowledgement Compliant / Open Access / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-15H04685, KAKENHI-PROJECT-15K15053, KAKENHI-PROJECT-15K21133, KAKENHI-PROJECT-15K08273, KAKENHI-PROJECT-15K08274, KAKENHI-PROJECT-16K19018
[Journal Article] Superoxide-Generating Nox5α Is Functionally Required for the Human T-Cell Leukemia Virus Type 1-Induced Cell Transformation Phenotype.2015
- Author(s)
  Shigemura T, Shiohara M, Kato M, Furuta S, Kaneda K, Morishita K, Hasegawa H, Fujii M, Gorlach A, Koike K, Kamata T.
- Journal Title
  
  J Virol.
  
  Volume: 89 Issue: 17 Pages: 9080-9
- DOI
  10.1128/jvi.00983-15
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-15K15087, KAKENHI-PROJECT-15H04704, KAKENHI-PROJECT-25293081, KAKENHI-PROJECT-15K21133
[Journal Article] Maintenance of the hematopoietic stem cell pool in bone marrow niches by EVI1-regulated GPR562013
- Author(s)
  Saito Y., Kaneda K., Suekane A., Ichihara E., Nakahata S., Yamakawa N., Nagai K., Mizuno N., Kogawa K., Miura I., Itoh H., and Morishita K..
- Journal Title
  
  Leukemia
  
  Volume: 27 Issue: 8 Pages: 1637-1649
- DOI
  10.1038/leu.2013.75
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-24590113, KAKENHI-PUBLICLY-25118720, KAKENHI-PROJECT-25293081, KAKENHI-PUBLICLY-23118523, KAKENHI-PUBLICLY-23121522
[Patent] 放射標識されたチロシン誘導体およびその用途2023
- Inventor(s)
  兼田加珠子、白神宜史、角永悠一郎、豊嶋厚史、深瀬浩一、長田宏
- Industrial Property Rights Holder
  国立大学法人大阪大学
- Industrial Property Rights Type
  特許
- Filing Date
  2023
- Overseas
- Data Source
  KAKENHI-PROJECT-21K07619
[Patent] ハロゲン化フェノール含有化合物の新規アスタチン-211(211At)標識化法の開発2022
- Inventor(s)
  深瀬浩一,豊嶋厚史,篠原厚,白神宜史,兼田加珠子,他2名
- Industrial Property Rights Holder
  国立大学法人大阪大学
- Industrial Property Rights Type
  特許
- Industrial Property Number
  2022-035169
- Filing Date
  2022
- Data Source
  KAKENHI-PROJECT-21K07619
[Patent] 放射標識されたFAPα親和性化合物およびその用途2022
- Inventor(s)
  白神宜史,角永悠一郎,兼田加珠子,渡部直史,深瀬浩一,他3名
- Industrial Property Rights Holder
  国立大学法人大阪大学
- Industrial Property Rights Type
  特許
- Industrial Property Number
  2022-026194
- Filing Date
  2022
- Data Source
  KAKENHI-PROJECT-21K07619
[Patent] 放射標識されたチロシン誘導体およびその用途2022
- Inventor(s)
  兼田加珠子、白神宜史、角永悠一郎、豊嶋厚史、深瀬浩一、長田宏
- Industrial Property Rights Holder
  国立大学法人大阪大学
- Industrial Property Rights Type
  特許
- Industrial Property Number
  2022-150608
- Filing Date
  2022
- Data Source
  KAKENHI-PROJECT-21K07619
[Patent] α線放出抗体薬物複合体2021
- Inventor(s)
  樺山一哉,深瀬浩一,角永悠一郎,兼田加珠子,真鍋良幸,他6名
- Industrial Property Rights Holder
  国立大学法人大阪大学, 公益財団法人野口研究所
- Industrial Property Rights Type
  特許
- Industrial Property Number
  2021-160158
- Filing Date
  2021
- Data Source
  KAKENHI-PROJECT-21K07619
[Patent] ボロン酸化合物およびその製造方法2021
- Inventor(s)
  白神宜史、兼田加珠子、角永悠一郎、豊嶋厚史、他4名
- Industrial Property Rights Holder
  白神宜史、兼田加珠子、角永悠一郎、豊嶋厚史、他4名
- Industrial Property Rights Type
  特許
- Industrial Property Number
  2021-052352
- Filing Date
  2021
- Data Source
  KAKENHI-PROJECT-18K07323
[Patent] 放射標識されたFAPα親和性化合物およびその用途2021
- Inventor(s)
  白神宜史,角永悠一郎,兼田加珠子,渡部直史,深瀬浩一,他3名
- Industrial Property Rights Holder
  国立大学法人大阪大学
- Industrial Property Rights Type
  特許
- Industrial Property Number
  2022-026194
- Filing Date
  2021
- Data Source
  KAKENHI-PROJECT-18K07323
[Patent] ボロン酸化合物およびその製造方法2021
- Inventor(s)
  白神宜史、兼田加珠子、渡部直史、角永悠一郞
- Industrial Property Rights Holder
  大阪大学
- Industrial Property Rights Type
  特許
- Industrial Property Number
  2021-052352
- Filing Date
  2021
- Data Source
  KAKENHI-PROJECT-20K08105
[Patent] ハロゲン化フェノール含有化合物の新規アスタチン-211(211At)標識化法の開発2021
- Inventor(s)
  深瀬浩一,豊嶋厚史,篠原厚,白神宜史,兼田加珠子,他2名
- Industrial Property Rights Holder
  国立大学法人大阪大学
- Industrial Property Rights Type
  特許
- Industrial Property Number
  2022-035169
- Filing Date
  2021
- Data Source
  KAKENHI-PROJECT-18K07323
[Patent] α線放出抗体薬物複合体2021
- Inventor(s)
  樺山一哉,深瀬浩一,角永悠一郎,兼田加珠子,真鍋良幸,他6名
- Industrial Property Rights Holder
  国立大学法人大阪大学
- Industrial Property Rights Type
  特許
- Industrial Property Number
  2021-160158
- Filing Date
  2021
- Data Source
  KAKENHI-PROJECT-18K07323
[Patent] 放射標識された化合物およびその用途2021
- Inventor(s)
  白神宜史,兼田加珠子,角永悠一郎,渡部直史,他3名
- Industrial Property Rights Holder
  国立大学法人大阪大学
- Industrial Property Rights Type
  特許
- Industrial Property Number
  2021-125774
- Filing Date
  2021
- Data Source
  KAKENHI-PROJECT-21K07619
[Patent] 放射標識された化合物およびその用途2021
- Inventor(s)
  白神宜史、兼田加珠子、角永悠一郎、他
- Industrial Property Rights Holder
  大阪大学
- Industrial Property Rights Type
  特許
- Industrial Property Number
  2021-125774
- Filing Date
  2021
- Data Source
  KAKENHI-PROJECT-20K08105
[Patent] 放射標識された化合物およびその用途2021
- Inventor(s)
  白神宜史,兼田加珠子,角永悠一郎,渡部直史,他3名
- Industrial Property Rights Holder
  国立大学法人大阪大学
- Industrial Property Rights Type
  特許
- Industrial Property Number
  2021-125774
- Filing Date
  2021
- Data Source
  KAKENHI-PROJECT-18K07323
[Patent] ２１１Ａｔ標識化アミノ酸誘導体を含む医薬組成物及びその製造方法2019
- Inventor(s)
  深瀬浩一、篠原厚、金井好克、樺山一哉、兼田加珠子、他5名
- Industrial Property Rights Holder
  国立大学法人大阪大学
- Industrial Property Rights Type
  特許
- Filing Date
  2019
- Overseas
- Data Source
  KAKENHI-PROJECT-18K07323
[Patent] ヒトインテグリンA6B4と特異的に反応する抗体2013
- Inventor(s)
  見供克之、甲田克志、黒澤仁、兼田加珠子、森下和広、黒澤良和
- Industrial Property Rights Holder
  見供克之、甲田克志、黒澤仁、兼田加珠子、森下和広、黒澤良和
- Industrial Property Rights Type
  特許
- Filing Date
  2013
- Data Source
  KAKENHI-PROJECT-25870564
[Presentation] [211At]PSMA5の薬物動態試験ならびにヒト吸収線量の推定2023
- Author(s)
  渡部直史、兼田加珠子、佐藤達彦、角永悠一朗、大江一弘、羽場宏光、豊嶋厚史、Jens Cardinale、Frederik L. Giesel、深瀬浩一、富山憲幸、白神宜史
- Organizer
  第63回日本核医学会学術総会
- Data Source
  KAKENHI-PROJECT-23K21426
[Presentation] 希少がん治療を目指した短寿命アルファ線核医学治療薬の開発.2023
- Author(s)
  兼田（中島）加珠子、王谷英達、渡部直史、真鍋良幸、下山敦史、樺山一哉、金井好克、豊嶋　厚史、篠原厚、深瀬浩一.
- Organizer
  第82回日本癌学会学術総会
- Data Source
  KAKENHI-PROJECT-21K07619
[Presentation] [211At]PSMA5の薬物動態試験ならびにヒト吸収線量の推定.2023
- Author(s)
  渡部直史、佐藤達彦、兼田加珠子、角永悠一郎、大江一弘、羽場宏光、豊嶋厚史、Frederik L. Giesel、深瀬浩一、富山憲幸、白神宜史.
- Organizer
  第43回日本核医学技術学会総会学術総会
- Data Source
  KAKENHI-PROJECT-21K07619
[Presentation] アスタチン-211標識線維芽細胞活性化タンパク質阻害薬（FAPI）の合成およびα線核医学治療の検討.2023
- Author(s)
  白神宜史、渡部直史、兼田加珠子、角永悠一郎、大江一弘、下山敦史、川上厚子、神野直哉、羽場宏光、豊嶋厚史、深瀬浩一.
- Organizer
  第63回日本核医学会学術総会・第43回日本核医学技術学会総会学術総会
- Data Source
  KAKENHI-PROJECT-21K07619
[Presentation] 前立腺がんの標的α線治療を目的とする[211At]PSMA5の製法と品質確立.2023
- Author(s)
  白神宜史、渡部直史、兼田（中島）加珠子、仲定宏、角永悠一郎、大江一弘、羽場宏光、Xiaojie Yin、神野直哉、豊嶋厚史、深瀬浩一.
- Organizer
  第63回日本核医学会学術総会・第43回日本核医学技術学会総会学術総会
- Data Source
  KAKENHI-PROJECT-21K07619
[Presentation] [211At]PSMA5の非臨床試験：First-in-human医師主導治験開始に向けて.2023
- Author(s)
  渡部直史、兼田加珠子、角永悠一郎、大江一弘、羽場宏光、豊嶋厚史、Jens Cardinale、Frederik L. Giesel、深瀬浩一、富山憲幸、白神宜史.
- Organizer
  第63回日本核医学会学術総会・第43回日本核医学技術学会総会学術総会
- Data Source
  KAKENHI-PROJECT-21K07619
[Presentation] Dispersion of alpha-nuclides during Animal Experiments.2022
- Author(s)
  (1)兼田（中島）加珠子
- Organizer
  第4回日本保健物理学会・日本放射線安全管理学会合同大会
- Invited
- Data Source
  KAKENHI-PROJECT-21K07619
[Presentation] 低侵襲治療を目指した短寿命アルファ線核医学治療薬の開発.2022
- Author(s)
  兼田（中島）加珠子、真鍋良幸、下山敦史、樺山一哉、金井好克、豊嶋　厚史、深瀬浩一、篠原厚.
- Organizer
  第81回日本癌学会学術総会
- Data Source
  KAKENHI-PROJECT-21K07619
[Presentation] Preparation of 211At-PSMA for TAT of prostate cancer2022
- Author(s)
  Yoshifumi Shirakami, Tadashi Watabe, Kazuko Kaneda-Nakashima, Yuichiro Kadonaga, Kazuhiro Ooe, Yang Wang, Hiromitsu Haba, Atsushi Toyoshima, Koichi Fukase
- Organizer
  日本核医学会学術総会
- Data Source
  KAKENHI-PROJECT-20K08105
[Presentation] Evaluation of new targeted alpoha therapy using astatine (211At)-labeled PSMA5 for prostate cancer.2022
- Author(s)
  Watabe T, Kaneda-Nakashima K, Toyoshima A, Fukase K.
- Organizer
  第81回日本癌学会学術総会
- Data Source
  KAKENHI-PROJECT-21K07619
[Presentation] Activities of Targeted Alpha Therapy using 211At at Osaka University in Japan2022
- Author(s)
  K. Kabayama, Y. Shirakami, K. Kaneda, T. Watabe, K. Ooe, A. Toyoshima, H. Kato, Y. Kadonaga, S. Naka, Y. Kon, M. Fukuda, N. Tomiyama, T. Nakano, K. Fukase
- Organizer
  The 12th International Symposium on Targeted Alpha Therapy (TAT12)
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-23K21426
[Presentation] Preparation of 211At-PSMA for TAT of prostate cancer.2022
- Author(s)
  Shirakami Y, Watabe T, Kaneda-Nakashima K, Kadonaga Y, Ooe K, Wang Y, Haba H, Toyoshima A, FukaseK.
- Organizer
  第62回日本核医学会学術総会・第42回日本核医学技術学会総合学術大会・第13回世界核医学会
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-21K07619
[Presentation] Development of 211At-labeled antibodies and investigation of their endocytosis and inhibition of tumor growth2021
- Author(s)
  Kazuya Kabayama, Kazuko Kaneda, Yoshiyuki Manabe, Atsushi Shimoyama, Atsushi Toyoshima, Atsushi Shinohara, Koichi Fukase
- Organizer
  Pacifichem 2021
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-23K21426
[Presentation] Extended single-dose toxicity study of [211At]NaAt in mice for the FIH clinical trial of targeted alpha therapy for differentiated thyroid cancer2021
- Author(s)
  Watabe T, Kaneda K, Ooe K, Liu Y, Kurimoto K, Toyoshima A, Shinohara A, Shirakami Y
- Organizer
  SNMMI Annual Meeting 2021
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-23K21426
[Presentation] Extended single-dose toxicity study of [211At]NaAt in mice for the FIH clinical trial of targeted alpha therapy for differentiated thyroid cancer2021
- Author(s)
  Tadashi Watabe, Kazuko Kaneda-Nakashima, Kazuhiro Ooe, Yuwei Liu, Kenta Kurimoto, Atsushi Toyoshima, Atsushi Shinohara, Yoshifumi Shirakami
- Organizer
  SNMMI 2021 Virtual Annual Meeting
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-21K07619
[Presentation] Enhanced therapeutic effect with repeated administration of [211At]NaAt for differentiated thyroid cancer in mice2021
- Author(s)
  Yuwei Liu, Tadashi Watabe, Kazuko Kaneda-Nakashima, Kazuhiro Ooe, Yoshifumi Shirakami, Atsushi Toyoshima, Eku Shimosegawa, Takashi Nakano, Atsushi Shinohara, Jun Hatazawa
- Organizer
  SNMMI 2021 Virtual Annual Meeting
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-21K07619
[Presentation] Extended single-dose toxicity study of [211At]NaAt in mice for the FIH clinical trial of targeted alpha therapy for differentiated thyroid cancer2021
- Author(s)
  Tadashi Watabe, Kazuko Kaneda-Nakashima, Kazuhiro Ooe, Yuwei Liu, Kenta Kurimoto, Atsushi Toyoshima, Atsushi Shinohara, Yoshifumi Shirakami
- Organizer
  SNMMI 2021 Virtual Annual Meeting
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-18K07323
[Presentation] Estimated absorbed dose in human after intravenous administration of [211At]NaAt for the FIH clinical trial of targeted alpha therapy2021
- Author(s)
  Watabe T, Sato T, Kaneda K, Ooe K, Liu Y, Kurimoto K, Toyoshima A, Shinohara A, Shirakami Y
- Organizer
  European Association of Nuclear Medicine (EANM’21)
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-23K21426
[Presentation] アスタチンを用いた難治性甲状腺がんに対するアルファ線核医学治療2021
- Author(s)
  渡部直史, 兼田加珠子, 白神宜史, 大江一弘, 豊嶋厚史, 篠原厚
- Organizer
  第58回アイソトープ・放射線研究発表会
- Data Source
  KAKENHI-PROJECT-18K07323
[Presentation] アスタチンを用いた難治性甲状腺がんに対するアルファ線核医学治療2021
- Author(s)
  渡部直史, 兼田加珠子, 白神宜史, 大江一弘, 豊嶋厚史, 篠原厚
- Organizer
  第58回アイソトープ・放射線研究発表会
- Data Source
  KAKENHI-PROJECT-21K07619
[Presentation] The comparison of therapeutic effect between [211At]NaAt and [131I]NaI: preclinical study using mice xenograft model of differentiated thyroid cancer2021
- Author(s)
  Yuwei Liu, Tadashi Watabe, Kazuko Kaneda-Nakashima, Kazuhiro Ooe, Yoshifumi Shirakami, Atsushi Toyoshima, Eku Shimosegawa, Takashi Nakano, Atsushi Shinohara, Jun Hatazawa
- Organizer
  SNMMI 2021 Virtual Annual Meeting
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-21K07619
[Presentation] The comparison of therapeutic effect between [211At]NaAt and [131I]NaI: preclinical study using mice xenograft model of differentiated thyroid cancer2021
- Author(s)
  Yuwei Liu, Tadashi Watabe, Kazuko Kaneda-Nakashima, Kazuhiro Ooe, Yoshifumi Shirakami, Atsushi Toyoshima, Eku Shimosegawa, Takashi Nakano, Atsushi Shinohara, Jun Hatazawa
- Organizer
  SNMMI 2021 Virtual Annual Meeting
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-18K07323
[Presentation] アスタト－脱ボロン酸反応による211At標識αメチルチロシンの製造と生物活性に関する研究2021
- Author(s)
  白神宜史，兼田加珠子，渡部直史，大江一弘，角永悠一郎，仲定宏，川上厚子，中山敏夫，近藤裕，豊嶋厚史，深瀬浩一
- Organizer
  第61回日本核医学会学術総会・第41回日本核医学技術学会総会学術大会
- Data Source
  KAKENHI-PROJECT-18K07323
[Presentation] アスタト－脱ボロン酸反応による211At標識αメチルチロシンの製造と生物活性に関する研究2021
- Author(s)
  白神宜史，兼田加珠子，渡部直史，大江一弘，角永悠一郎，仲定宏，川上厚子，中山敏夫，近藤裕，豊嶋厚史，深瀬浩一
- Organizer
  第61回日本核医学会学術総会・第41回日本核医学技術学会総会学術大会
- Data Source
  KAKENHI-PROJECT-21K07619
[Presentation] 万能治療を目指した短寿命アルファ線核医学治療薬の開発.2021
- Author(s)
  兼田（中島）加珠子, 真鍋良幸, 下山敦史, 樺山一哉, 金井好克, 豊嶋　厚史, 深瀬浩一, 篠原厚.
- Organizer
  第80回日本癌学会学術総会
- Data Source
  KAKENHI-PROJECT-18K07323
[Presentation] 万能治療を目指した短寿命アルファ線核医学治療薬の開発2021
- Author(s)
  兼田（中島）加珠子, 真鍋良幸, 下山敦史, 樺山一哉, 金井好克, 豊嶋　厚史, 深瀬浩一, 篠原厚
- Organizer
  第80回日本癌学会学術総会
- Data Source
  KAKENHI-PROJECT-21K07619
[Presentation] 核医学治療を志向したα線放出核種標識抗体の創製と機能評価2021
- Author(s)
  山本竜駒, 樺山一哉, 兼田加珠子, 世良田聡, 仲哲治, 篠原厚, 深瀬浩一
- Organizer
  日本化学会第101春季年会(2021)
- Data Source
  KAKENHI-PROJECT-21K07619
[Presentation] 核医学治療を志向したα線放出核種標識抗体の創製と機能評価.2021
- Author(s)
  山本竜駒, 樺山一哉, 兼田加珠子, 世良田聡, 仲哲治, 篠原厚, 深瀬浩一.
- Organizer
  日本化学会第101春季年会(2021)
- Data Source
  KAKENHI-PROJECT-18K07323
[Presentation] Enhanced therapeutic effect with repeated administration of [211At]NaAt for differentiated thyroid cancer in mice2021
- Author(s)
  Yuwei Liu, Tadashi Watabe, Kazuko Kaneda-Nakashima, Kazuhiro Ooe, Yoshifumi Shirakami, Atsushi Toyoshima, Eku Shimosegawa, Takashi Nakano, Atsushi Shinohara, Jun Hatazawa
- Organizer
  SNMMI 2021 Virtual Annual Meeting
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-18K07323
[Presentation] 核医学利用に向けたアスタチン化ナトリウム[211At]NaAtの高純度調製.2020
- Author(s)
  白神宜史、大江一弘、兼田加珠子、寺本高啓、渡部直史、豊嶋厚史、篠原厚、畑澤順
- Organizer
  日本放射化学会第64回討論会
- Data Source
  KAKENHI-PROJECT-18K07323
[Presentation] 還元剤による[211At]NaAtの調製とイオン対逆相HPLC分析2020
- Author(s)
  白神宜史, 兼田加珠子, 渡部直史, 大江一弘, 劉雨薇, 寺本高啓, 豊嶋厚史, 篠原厚, 中野貴志, 下瀬川恵久, 畑澤順
- Organizer
  第60回日本核医学会総会学術集会
- Data Source
  KAKENHI-PROJECT-18K07323
[Presentation] Development of targeted alpha therapy with 225-actinium2020
- Author(s)
  Atsushi Toyoshima, Tadashi Watabe, Kazuko Kaneda, Kojiro Nagata, Takashi Yoshimura, Atsushi Shinohara, Frederik Giesel, Jun Hatazawa
- Organizer
  GIMRT Joint International Symposium on Radiation Effects in Materials and Actinide Science: GIMRT-REMAS2020
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-18K07323
[Presentation] がん細胞型アミノ酸トランスポーターを標的としたAt-211標識核医学治療薬の検討.2020
- Author(s)
  兼田加珠子、白神宜史、大江一弘、寺本高啓、渡部直史、下山敦史、真鍋良幸、樺山一哉、豊嶋厚史、深瀬浩一、篠原厚
- Organizer
  日本放射化学会第64回討論会
- Data Source
  KAKENHI-PROJECT-18K07323
[Presentation] アスタチン-211 標識金ナノ粒子の安定性評価2019
- Author(s)
  角永悠一郎, 黄栩昊, 張子見, 兼田加珠子, 大江一弘, 寺本高啓, 下山敦史, 樺山一哉, 豊嶋厚史, 篠原厚, 深瀬浩一
- Organizer
  日本放射化学会第63回討論会
- Data Source
  KAKENHI-PROJECT-18K07323
[Presentation] がん細胞型アミノ酸トランスポーターを標的とした短寿命アルファ線核医学治療薬の開発2019
- Author(s)
  兼田加珠子
- Organizer
  第78回　日本癌学会学術総会
- Data Source
  KAKENHI-PROJECT-18K07323
[Presentation] Targeted alpha therapy of thyroid cancer: evaluation of [At-211]NaAt treatment in the xenograft model.2019
- Author(s)
  Watabe T, Kaneda K, Liu Y, Shirakami Y, Ooe K, Toyoshima A, Shimosegawa E, Fukuda M, Shinohara A, Hatazawa
- Organizer
  第59回日本核医学会学術総会
- Data Source
  KAKENHI-PROJECT-19H03602
[Presentation] がん間質を標的とするα線治療薬255Ac-FAPI-04の研究2019
- Author(s)
  白神宜史, 渡部直史, Yuwei Liu, 兼田加珠子, 永田光知郎, 豊嶋厚史, 下瀬川恵久,篠原厚,畑澤順, Frederik Giesel
- Organizer
  第3回放射性薬品科学研究会／第19回放射性医薬品・画像診断薬研究会
- Data Source
  KAKENHI-PROJECT-18K07323
[Presentation] Enhancement of astatine-211 uptake via the sodium iodide symporter by the addition of ascorbic acid in targeted alpha therapy of thyroid cancer2019
- Author(s)
  Tadashi Watabe, Kazuko Kaneda-Nakashima, Yuwei Liu, Yoshifumi Shirakami, Kazuhiro Ooe, Atsushi Toyoshima, Eku Shimosegawa, Mitsuhiro Fukuda, Atsushi Shinohara, Jun Hatazawa.
- Organizer
  第14回日本分子イメージング学会総会
- Data Source
  KAKENHI-PROJECT-18K07323
[Presentation] Theranostics targeting fibroblast activation protein in the tumor stroma: [64Cu] and [225Ac] labelled FAPI-04 in pancreatic cancer xenograft mice.2019
- Author(s)
  Watabe T, Shirakami Y, Kaneda K, Liu Y, Lindner T, Ooe K, Toyoshima A, Naka S, Shimosegawa E, Haberkorn Uwe; Giesel F, Hatazawa J.
- Organizer
  ヨーロッパ核医学会（EANM2019）
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-19H03602
[Presentation] 放射線の種類弁別可能なイメージング装置開発とα線分布計測への応用2019
- Author(s)
  山本誠一, 渡部直史, 兼田加珠子, 白神宣史, 大江一弘, 篠原厚, 豊嶋厚史, 畑澤順.
- Organizer
  第14回日本分子イメージング学会総会
- Data Source
  KAKENHI-PROJECT-18K07323
[Presentation] 水溶液中におけるボロノ基-アスタチン交換反応の特異性の解明2019
- Author(s)
  尾幡穂乃香, 白神宜史, 兼田加珠子, 大江一弘, 永田光知郎, 寺本高啓, 市村聡一朗, 中川創太, 吉村崇豊嶋厚史, 篠原厚.
- Organizer
  日本放射化学会第63回討論会
- Data Source
  KAKENHI-PROJECT-18K07323
[Presentation] アルファ線核医学治療に向けたAt-211標識アミノ酸誘導体の検討.2018
- Author(s)
  張子見, 兼田加珠子, 豊嶋厚史, 深瀬浩一, 篠原厚.
- Organizer
  第62回放射化学討論会（日本放射化学会年会）
- Data Source
  KAKENHI-PROJECT-18K07323
[Presentation] アミノ酸トランスポーターLAT1を標的とするα線がんミサイル療法の開発.2018
- Author(s)
  兼田　加珠子, 張子見, 真鍋良幸, 下山敦史, 樺山一哉, 白神　宜史, 金井好克, 畑澤　順, 深瀬浩一, 篠原厚.
- Organizer
  第91回日本生化学会大会
- Data Source
  KAKENHI-PROJECT-18K07323
[Presentation] Enhancement of At-211 uptake in the thyroid gland: SPECT study in rats.2018
- Author(s)
  Yuwei Liu, Tadashi Watabe, Kazuko Kaneda-Nakashima, Yoshifumi Shirakami, Atsushi Toyoshima, Mitsuaki Tatsumi, Eku Shimosegawa, Mitsuhiro Fukuda, Atsushi Shinohara, Jun Hatazawa.
- Organizer
  日本分子イメージング学会第13回学会総会・学術集会
- Data Source
  KAKENHI-PROJECT-18K07323
[Presentation] がん細胞型アミノ酸トランスポーターを標的とした新規核医学治療薬の開発.2018
- Author(s)
  兼田（中島）加珠子, 張子見, 真鍋良幸, 下山敦史, 樺山一哉, 金井好克, 深瀬浩一, 篠原厚.
- Organizer
  第77回日本癌学会学術総会
- Data Source
  KAKENHI-PROJECT-18K07323
[Presentation] SNX13のハプロ不全はEVI1高発現AMLのmonosomy7における原因遺伝子として白血病化に寄与している.2018
- Author(s)
  小河穂波, 末金彰, 齋藤祐介, 兼田加珠子, ナーウィンマナチャイ, 森下和広.
- Organizer
  第77回日本癌学会学術総会
- Data Source
  KAKENHI-PROJECT-18K07323
[Presentation] 動物実験における短寿命アルファ線核種の体内外の分布2018
- Author(s)
  兼田（中島）加珠子, 篠原厚, 吉村崇, 豊嶋厚史, 張子見, 永田光知郎, 渡部直史, 大江一弘, 山村朝雄, 白崎謙次, 菊永英寿, 羽場宏光, 鷲山幸信
- Organizer
  日本放射線安全管理学会第17回学術大会
- Data Source
  KAKENHI-PROJECT-18K07323
[Presentation] Chemical properties of 211At-NaAt and its biological behaviors in small animals.2018
- Author(s)
  Yoshifumi Shirakami, Victor Romanov, Tadashi Watabe, Kazuko Kaneda, Yuwai Liu, Atsushi Shinohara, Eku Shimosegawa, Jun Hatazawa.
- Organizer
  第58回　日本核医学会学術総会
- Data Source
  KAKENHI-PROJECT-18K07323
[Presentation] EVI1 によって制御される CGRP-CRLR/RAMP1シグナルは白血病化を促進する.2018
- Author(s)
  末金彰, 齋藤祐介, 中畑新吾, 小河穂波, 市川朝永, ナーウィンマナチャイ, マーチンジュリアナ, 兼田加珠子, 大里元美, 森下和広.
- Organizer
  第77回日本癌学会学術総会
- Data Source
  KAKENHI-PROJECT-18K07323
[Presentation] 短寿命α線核種の合理的規制のためのデータ取得による安全性検証と安全管理・教育方法の開発.2018
- Author(s)
  篠原厚, 吉村崇, 豊嶋厚史, 兼田加珠子, 張子見, 永田光知郎, 渡部直史, 大江一弘, 畑澤順, 山村朝雄, 白崎謙次, 菊永英寿, 羽場宏光, 鷲山幸信.
- Organizer
  第62回放射化学討論会（日本放射化学会年会）
- Data Source
  KAKENHI-PROJECT-18K07323
[Presentation] 難治性がん治療のための短寿命 RI 標識分子の合成と利用.2018
- Author(s)
  樺山一哉, 兼田加珠子, 張子見, 真鍋良幸, 下山敦史, 豊嶋厚史, 篠原厚, 深瀬浩一.
- Organizer
  第12回バイオ関連化学シンポジウム（第33回生体機能関連化学シンポジウム, 第21回バイオテクノロジー部会シンポジウム）
- Data Source
  KAKENHI-PROJECT-18K07323
[Presentation] A novel molecular target therapy for therapy-resistant AML by human anti ITGA6/B4 antibody.2016
- Author(s)
  Kazuko Kaneda, Yusuke Saito, Akira Suekane, Shingo Nakahata, Gene Kurosawa, Koichi Sato, Yukio Sudo, Kazuhiro Morishita.
- Organizer
  The Latest Advances in Hematological Cancer Research: From Basic Science to Therapeutics. The 5th JCA-AACR Special Joint Conference.
- Place of Presentation
  Tokyo Bay Maihama Hotel Club Resort
- Year and Date
  2016-07-13
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-15K21133
[Presentation] アミノ酸トランスポーターLAT1阻害によるがん転移抑制効果の検討.2016
- Author(s)
  兼田加珠子，魏玲，Pornparn Kongpracha，大垣隆一，永森收志，金井好克.
- Organizer
  第130回　日本薬理学会近畿部会
- Place of Presentation
  京都大学百周年時計台記念館
- Data Source
  KAKENHI-PROJECT-15K21133
[Presentation] LAT1阻害薬の抗がん剤耐性株への効果の検討.2016
- Author(s)
  兼田（中島）加珠子, 陳映安, 伊藤万理子, Quan Lili, Ling Wei, Pornparn Kongpracha, 大垣隆一, 永森收志, 金井好克.
- Organizer
  第11回トランスポーター研究会年会
- Place of Presentation
  京都大学　宇治キャンパスきはだホール
- Year and Date
  2016-07-02
- Data Source
  KAKENHI-PROJECT-15K21133
[Presentation] Effects of non-competitive LAT1-inhibitor on anti-cancer drug-resistant cell lines, LAT12016
- Author(s)
  兼田加珠子, 永森收志, 疋田隼人, 竹原徹郎, 金井好克.
- Organizer
  第75回　日本癌学会学術総会
- Place of Presentation
  パシフィコ横浜
- Year and Date
  2016-10-06
- Data Source
  KAKENHI-PROJECT-15K21133
[Presentation] Investigation of regulation mechanisms of cancer specific amino acid transporter, LAT1.2015
- Author(s)
  兼田（中島）加珠子, 永森收志, 金井好克.
- Organizer
  第74回日本癌学会学術総会
- Place of Presentation
  名古屋国際会議場
- Year and Date
  2015-10-08
- Data Source
  KAKENHI-PROJECT-15K21133
[Presentation] PIポリアミドを用いたEVI1依存的GPR56転写制御2015
- Author(s)
  兼田（中島）加珠子、下崎俊介、末金彰、斎藤祐介、渡部隆義、長瀬浩喜　森下和広
- Organizer
  第77回日本血液学会、
- Place of Presentation
  石川県立音楽堂（石川県金沢市）
- Year and Date
  2015-10-16
- Data Source
  KAKENHI-PROJECT-25293081
[Presentation] アミノ酸トランスポーター阻害薬による抗腫瘍薬作用増強効果についての検討2015
- Author(s)
  兼田加珠子, Pornparn Kongpracha, Ling Wei, 大垣隆一, 永森收志, 金井好克.
- Organizer
  第37回生体膜と薬物のシンポジウム
- Place of Presentation
  熊本大学薬学部
- Year and Date
  2015-11-19
- Data Source
  KAKENHI-PROJECT-15K21133
[Presentation] Inhibitor of amino acid transporter is useful as a novel anti-cancer drug.2015
- Author(s)
  兼田（中島）加珠子, 疋田隼人, Pornparn Kongpracha, Ling Wei, 大垣隆一, 永森收志, 竹原徹郎, 金井好克.
- Organizer
  38回日本分子生物学会年会・第88回日本生化学会大会合同大会
- Place of Presentation
  神戸ポートアイランド
- Year and Date
  2015-12-01
- Data Source
  KAKENHI-PROJECT-15K21133
[Presentation] アミノ酸輸送体阻害薬による抗がん剤作用増強効果についての検討2015
- Author(s)
  兼田加珠子, Pornparn Kongpracha, Ling Wei, 大垣隆一, 永森收志, 金井好克.
- Organizer
  第24回日本Cell Death学会学術集会
- Place of Presentation
  大阪大学会館
- Year and Date
  2015-07-11
- Data Source
  KAKENHI-PROJECT-15K21133
[Presentation] Inhibition of GPR56 by PI-polyamide targeting the EVI1-binding site with suppression of leukemia.2015
- Author(s)
  Kazuko Kaneda-Nakashima, Yusuke Saito, Akira Suekane, Shunsuke Shimosaki, Kazuhiro Morishita.
- Organizer
  International society for experimental hematology, 44th annual scientific meeting.
- Place of Presentation
  Kyoto International Conference Center
- Year and Date
  2015-09-17
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-15K21133
[Presentation] Leucine transported by cancer-type amino acid transporter LAT1 affects multiple cellular processes in pancreatic cancer cells.2015
- Author(s)
  Pornparn Kongpracha, Noriyuki Isozumi, Pattama Wiriyasermkul, Kazuko Kaneda-Nakashima, Suguru Okuda, Ryuichi Ohgaki, Shushi Nagamori, Yoshikatsu Kanai.
- Organizer
  38回日本分子生物学会年会・第88回日本生化学会大会合同大会
- Place of Presentation
  神戸ポートアイランド
- Year and Date
  2015-12-01
- Data Source
  KAKENHI-PROJECT-15K21133
[Presentation] Integrin A6 as a special marker of refractory leukemia is important for maintaining of leukemia stem cells.2013
- Author(s)
  Kaneda K, Morishita K.
- Organizer
  第11回幹細胞研究会
- Place of Presentation
  東京大学伊藤国際学術研究センター
- Data Source
  KAKENHI-PROJECT-25870564
[Presentation] 骨軟骨分化制御におけるMEL1/PRDM16の機能解析2013
- Author(s)
  兼田（中島）加珠子、井川加織、大田智美、黒木修司、関本朝久、帖佐悦男、迫田隅男、森下和広
- Organizer
  第36回　日本分子生物学会
- Place of Presentation
  神戸ポートアイランド
- Data Source
  KAKENHI-PROJECT-24592772
[Presentation] Investigation of therapeutic efficacy of neutralizing antibody of integrin for AML.2013
- Author(s)
  Kaneda K, Suekane A, Saito Y, Kurosawa J. Morishita K.
- Organizer
  第72回日本癌学会学術集会
- Place of Presentation
  パシフィコ横浜
- Data Source
  KAKENHI-PROJECT-25870564
[Presentation] Survival and drug resistance of LSCs Cell by integrin alpha 6 in EVI1high AML.2013
- Author(s)
  Kaneda K, Suekane A, Yamakawa N, Saito Y, Morishita K.
- Organizer
  第75回日本血液学会学術集会
- Place of Presentation
  ロイトン札幌
- Data Source
  KAKENHI-PROJECT-25870564
[Presentation] MEL1/PRDM16による骨分化制御機構の解明2013
- Author(s)
  兼田加珠子、井川加織、大田智美、関本朝久、帖佐悦夫、迫田澄男、森下和広
- Organizer
  第86回　日本生化学会大会
- Place of Presentation
  パシフィコ横浜
- Data Source
  KAKENHI-PROJECT-24592772
[Presentation] MEL1/PRDM16による骨分化制御機構の解明2012
- Author(s)
  兼田加珠子、井川加織、黒木修司、関本朝久、帖佐悦男、迫田隅男、森下和広
- Organizer
  第35回　日本分子生物学会年会
- Place of Presentation
  福岡国際会議場・マリンメッセ福岡
- Data Source
  KAKENHI-PROJECT-24592772
[Presentation] MEL/1PRDM16による骨分化制御機構の解明.
- Author(s)
  兼田(中島)加珠子、井川香織、太田智美、岡本朝久、帖佐悦男、迫田隅男、森下和広
- Organizer
  第86回日本生化学会大会.
- Place of Presentation
  横浜市　パシフィコ横浜
- Data Source
  KAKENHI-PROJECT-25293081
[Presentation] ATLやその他のがんにおけるNDRG2発現低下はPTENリン酸化異常をきたし、PI3K/AKT経路を活性化させる　（第76回日本血液学会学術集会　　2014.11.1　大阪）ポスター
- Author(s)
  兼田加珠子、井川加織、太田智美、関本朝久、帖佐悦男、迫田隅男、今泉和則、ﾏﾆｻｲ･ﾌﾟﾃﾞｨ、山口良二、森下和広
- Organizer
  第87回日本生化学会大会
- Place of Presentation
  京都国際会館
- Year and Date
  2014-10-16 – 2014-10-18
- Data Source
  KAKENHI-PROJECT-25293081
[Presentation] Improvement therapeutic efficacy by neutralizing antibody of integrinA6/B4 for EVI1 high AML （
- Author(s)
  Kazuko Kaneda-Nakashima, Akira Suekane, Jin Kurosawa, Yuko Sudo, Akiyuki Furuya, Kazuhiro Morishita
- Organizer
  第76回日本血液学会学術集会
- Place of Presentation
  大阪国際会議場
- Year and Date
  2014-10-31 – 2014-11-02
- Data Source
  KAKENHI-PROJECT-25293081
[Presentation] Integrin A6 as a special marker of refractory leukemia is important for maintaining of leukemia stem cells.
- Author(s)
  Kaneda K, Morishita K.
- Organizer
  The 11th Stem Cell Research Symposium.
- Place of Presentation
  文京区　東京大学
- Data Source
  KAKENHI-PROJECT-25293081
[Presentation] Investigation of MEL1/PRDM16 function in bone differentiation.
- Author(s)
  Kaneda-Nakashima K, Igawa K, Ohta T, Sekimoto T, Chosa E, Imaizumi K, Phudit M, Yamaguchi R, Sakoda S, Morishita K.
- Organizer
  第87回日本生化学会大会
- Place of Presentation
  国立京都国際会館(京都府京都市）
- Year and Date
  2014-10-15 – 2014-10-18
- Data Source
  KAKENHI-PROJECT-24592772
[Presentation] Improvement therapeutic efficacy by neutralizing antibody of integrinA6/B4 for EVI1high AML.
- Author(s)
  Kaneda-Nakashima K, Suekane A, Kurosawa J, Sudou Y, Furuya A, Morishita K.
- Organizer
  第76回日本血液学会学術集会
- Place of Presentation
  大阪国際会議場
- Year and Date
  2014-10-31 – 2014-11-02
- Data Source
  KAKENHI-PROJECT-25870564

1. Shirakami Yoshifumi (00560400)

# of Collaborated Projects: 6 results

# of Collaborated Products: 48 results
2. Watabe Tadashi (90648932)

# of Collaborated Projects: 4 results

# of Collaborated Products: 6 results
3. Yoshimura Takashi (90323336)

# of Collaborated Projects: 3 results

# of Collaborated Products: 0 results
4. 豊嶋厚史 (40414578)

# of Collaborated Projects: 3 results

# of Collaborated Products: 2 results
5. MORISHITA Kazuhiro (80260321)

# of Collaborated Projects: 2 results

# of Collaborated Products: 0 results
6. 永田光知郎 (10806871)

# of Collaborated Projects: 2 results

# of Collaborated Products: 0 results
7. 仲定宏 (60599843)

# of Collaborated Projects: 2 results

# of Collaborated Products: 1 results
8. 深瀬浩一 (80192722)

# of Collaborated Projects: 2 results

# of Collaborated Products: 0 results
9. 大江一弘 (90610303)

# of Collaborated Projects: 2 results

# of Collaborated Products: 2 results
10. 樺山一哉 (00399974)

# of Collaborated Projects: 2 results

# of Collaborated Products: 3 results
11. IGAWA Kaori (90423722)

# of Collaborated Projects: 1 results

# of Collaborated Products: 4 results
12. TANIWAKI Masfumi (80163640)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
13. NAKAHATA Shingo (80437938)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
14. ICHIKAWA Tomonaga (80586230)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
15. NISHIKATA Ichiro (50253844)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
16. 下瀬川恵久 (30370258)

# of Collaborated Projects: 1 results

# of Collaborated Products: 2 results
17. 篠原厚 (60183050)

# of Collaborated Projects: 1 results

# of Collaborated Products: 1 results
18. 福田光宏 (60370467)

# of Collaborated Projects: 1 results

# of Collaborated Products: 1 results
19. 畑澤順 (70198745)

# of Collaborated Projects: 1 results

# of Collaborated Products: 2 results
20. 白崎謙次 (70447176)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
21. 佐藤達彦 (30354707)

# of Collaborated Projects: 1 results

# of Collaborated Products: 2 results
22. 佐々木秀隆 (10738628)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
23. OHGAKI Ryuichi

# of Collaborated Projects: 0 results

# of Collaborated Products: 2 results
24. NAGAMORI Shushi

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
25. 森下和弘

# of Collaborated Projects: 0 results

# of Collaborated Products: 10 results
26. 奥田傑

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
27. 金井好克

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
28. 水野憲一

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results

Kaneda Kazuko 兼田 加珠子 (中島 加珠子)

中島 加珠子

中島加珠子

KANEDA Kazuko 兼田 加珠子

Research Projects

Research Products

Co-Researchers

転移・再発がんを標的とする革新的アルファ線がん治療薬の開発Principal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

A challenge to low-invasive one-day cancer treatment using alpha emitting nuclidePrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Development of cancer missile therapy targeting amino acid transporter LAT1 by alpha emitting nuclidePrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Investigation of cancer specific survival system via LAT1/4F2hc-integrin complexPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Investigation of survival strategy of refractory leukemia via integrinPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Principal Investigator

Project Period (FY)

Research Category

Kaneda Kazuko 兼田加珠子 (中島加珠子)

中島加珠子

KANEDA Kazuko 兼田加珠子